XML 50 R41.htm IDEA: XBRL DOCUMENT v3.22.2

Net (Loss) Income Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Net Income Per Share [Abstract]
Exercise of outstanding stock options, antidilutive	646,401		646,401
Exercise of outstanding stock options, dilutive		494,385		510,208
Exercise outstanding stock options (in Dollars)		$ 23,857		$ 7,764

X

- Definition

The value of exercise outstanding stock options.

+ References

No definition available.

+ Details

Name:	palt_ExerciseOutstandingStockOptions
Namespace Prefix:	palt_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	palt_NetIncomePerShareAbstract
Namespace Prefix:	palt_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Shares issued on exercise of outstanding stock options.

+ References

No definition available.

+ Details

Name:	palt_SharesIssuedOnExerciseOfOutstandingStockOptions
Namespace Prefix:	palt_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration